NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IndexRUT P/E24.37 EPS (ttm)1.21 Insider Own4.21% Shs Outstand32.13M Perf Week-1.04%
Market Cap950.45M Forward P/E4.21 EPS next Y7.02 Insider Trans-12.13% Shs Float30.79M Perf Month1.34%
Enterprise Value1.70B PEG- EPS next Q1.66 Inst Own116.14% Short Float15.64% Perf Quarter-0.47%
Income43.89M P/S1.43 EPS this Y6.82% Inst Trans-1.82% Short Ratio14.68 Perf Half Y1.75%
Sales664.28M P/B4.05 EPS next Y1.89% ROA3.20% Short Interest4.82M Perf YTD3.21%
Book/sh7.30 P/C4.37 EPS next 5Y-1.66% ROE19.23% 52W High42.29 -30.07% Perf Year-7.10%
Cash/sh6.77 P/FCF4.84 EPS past 3/5Y0.01% - ROIC3.87% 52W Low23.23 27.29% Perf 3Y71.32%
Dividend Est.- EV/EBITDA4.78 Sales past 3/5Y31.63% 16.31% Gross Margin57.69% Volatility2.22% 2.33% Perf 5Y62.65%
Dividend TTM- EV/Sales2.56 EPS Y/Y TTM-51.97% Oper. Margin24.90% ATR (14)0.75 Perf 10Y57.37%
Dividend Ex-Date- Quick Ratio1.01 Sales Y/Y TTM17.17% Profit Margin6.61% RSI (14)50.62 Recom1.50
Dividend Gr. 3/5Y- - Current Ratio1.08 EPS Q/Q-89.60% SMA20-0.55% Beta0.64 Target Price41.25
Payout0.00% Debt/Eq4.12 Sales Q/Q22.66% SMA502.61% Rel Volume0.83 Prev Close29.93
Employees357 LT Debt/Eq3.84 EarningsMay 08 AMC SMA200-5.38% Avg Volume328.14K Price29.57
IPOMay 07, 2015 Option/ShortYes / Yes EPS/Sales Surpr.4.01% 3.38% Trades Volume271,079 Change-1.20%
Date Action Analyst Rating Change Price Target Change
Jan-10-25Upgrade Needham Hold → Buy $46
Jul-30-24Upgrade H.C. Wainwright Neutral → Buy $47
Jun-07-24Upgrade Jefferies Hold → Buy $41 → $44
May-10-24Downgrade Piper Sandler Overweight → Neutral $39
May-10-24Downgrade Needham Buy → Hold
Jan-04-24Downgrade Jefferies Buy → Hold $30 → $37
Aug-25-23Reiterated Needham Buy $35 → $36
May-02-23Resumed Jefferies Buy $30
Aug-08-22Downgrade H.C. Wainwright Buy → Neutral
Feb-15-22Upgrade Cantor Fitzgerald Neutral → Overweight $18 → $26
Today 06:24AM
Jun-10-25 04:40AM
Jun-05-25 11:31PM
May-19-25 04:01PM
May-12-25 08:05AM
03:42AM Loading…
May-09-25 03:42AM
May-08-25 05:30PM
05:15PM
04:11PM
04:01PM
May-07-25 06:15PM
05:20PM
10:28AM
May-01-25 10:01AM
Apr-28-25 12:12PM
09:01AM Loading…
09:01AM
Apr-24-25 08:00AM
03:55AM
Apr-23-25 09:40AM
Apr-16-25 02:41PM
Apr-14-25 05:11AM
Apr-02-25 05:05AM
Apr-01-25 08:00AM
Mar-27-25 08:00AM
Mar-26-25 07:00AM
Mar-18-25 03:22PM
Mar-17-25 07:00AM
Mar-10-25 06:57PM
Mar-04-25 08:00AM
Mar-01-25 06:45AM
07:05AM Loading…
Feb-28-25 07:05AM
02:37AM
Feb-27-25 07:00PM
05:45PM
04:52PM
04:28PM
04:01PM
Feb-26-25 09:15AM
08:12AM
07:53AM
Feb-13-25 08:00AM
Feb-05-25 08:00AM
Jan-09-25 08:30AM
Jan-08-25 08:00AM
Nov-13-24 09:40AM
Nov-12-24 08:00AM
Nov-08-24 10:03AM
08:34AM
Nov-07-24 06:30PM
05:35PM
04:34PM
04:02PM
04:01PM
Nov-06-24 07:25AM
Oct-31-24 10:01AM
Oct-28-24 09:40AM
Oct-24-24 08:00AM
Oct-11-24 09:40AM
Oct-09-24 05:55PM
Oct-04-24 02:37PM
Sep-25-24 09:40AM
Sep-09-24 12:00PM
09:40AM
Sep-07-24 01:28AM
Sep-04-24 08:00AM
Aug-30-24 08:00AM
Aug-28-24 08:00AM
Aug-08-24 09:59PM
06:00PM
05:25PM
04:20PM
04:01PM
Aug-07-24 09:15AM
Aug-01-24 10:01AM
06:30AM
Jul-31-24 06:53AM
Jul-30-24 09:33AM
Jul-29-24 06:00AM
Jul-25-24 08:00AM
Jun-24-24 12:56PM
Jun-13-24 08:00AM
Jun-10-24 05:16PM
Jun-09-24 01:07AM
Jun-06-24 02:32AM
May-30-24 02:40AM
May-29-24 08:00AM
May-13-24 09:31AM
08:00AM
May-10-24 02:01PM
12:17PM
09:51AM
04:48AM
May-09-24 06:00PM
05:40PM
04:36PM
04:02PM
04:01PM
May-07-24 09:15AM
May-02-24 10:01AM
Apr-29-24 09:45AM
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Freund John GordonDirectorJun 09 '25Option Exercise13.4515,000201,75077,259Jun 11 05:04 PM
Freund John GordonDirectorJun 09 '25Sale30.626,601202,14970,658Jun 11 05:04 PM
Freund John GordonDirectorJun 09 '25Proposed Sale30.626,601202,148Jun 09 01:02 PM
Tupper ColleenEVP & Chief Financial OfficerMar 21 '25Sale30.036,396192,069156,667Mar 24 05:06 PM
Tupper ColleenEVP & Chief Financial OfficerMar 20 '25Sale30.001,20636,181163,063Mar 24 05:06 PM
Dreyer ScottEVP & Chief Commercial OfficerMar 21 '25Sale30.0318,881566,983103,613Mar 24 05:05 PM
Dreyer ScottEVP & Chief Commercial OfficerMar 20 '25Sale30.001,92757,811122,494Mar 24 05:05 PM
Tupper ColleenOfficerMar 21 '25Proposed Sale30.036,396192,069Mar 21 04:35 PM
Dreyer ScottOfficerMar 21 '25Proposed Sale30.0318,881566,984Mar 21 04:21 PM
Tupper ColleenOfficerMar 20 '25Proposed Sale30.001,20636,181Mar 20 04:32 PM
Kuhlmann Shirley R.Former OfficerMar 20 '25Proposed Sale29.6540,4941,200,632Mar 20 04:19 PM
Dreyer ScottOfficerMar 20 '25Proposed Sale30.001,92757,811Mar 20 04:17 PM
Tupper ColleenEVP & Chief Financial OfficerMar 14 '25Sale30.0097729,313164,269Mar 18 05:35 PM
Dreyer ScottEVP & Chief Commercial OfficerMar 14 '25Sale30.002,25567,661124,421Mar 18 05:34 PM
Tupper ColleenOfficerMar 14 '25Proposed Sale30.0097729,313Mar 14 04:06 PM
Dreyer ScottOfficerMar 14 '25Proposed Sale30.002,25567,661Mar 14 03:55 PM
Dreyer ScottEVP & Chief Commercial OfficerMar 06 '25Sale30.0015,387461,672126,676Mar 13 04:50 PM
Tupper ColleenEVP & Chief Financial OfficerMar 11 '25Sale30.0110,445313,413165,246Mar 13 04:49 PM
Tupper ColleenOfficerMar 11 '25Proposed Sale30.0110,445313,413Mar 11 04:16 PM
Dreyer ScottOfficerMar 11 '25Proposed Sale30.0015,387461,672Mar 11 04:08 PM
Tupper ColleenEVP & Chief Financial OfficerMar 06 '25Sale30.001,94958,470177,195Mar 10 04:02 PM
Tupper ColleenEVP & Chief Financial OfficerMar 07 '25Sale30.001,50445,121175,691Mar 10 04:02 PM
Dreyer ScottEVP & Chief Commercial OfficerMar 06 '25Sale30.003,29598,854144,411Mar 10 04:01 PM
Dreyer ScottEVP & Chief Commercial OfficerMar 07 '25Sale30.002,34870,446142,063Mar 10 04:01 PM
Dreyer ScottOfficerMar 07 '25Proposed Sale30.002,34870,446Mar 07 04:21 PM
Tupper ColleenOfficerMar 07 '25Proposed Sale30.001,50445,121Mar 07 04:13 PM
Kuhlmann Shirley R.EVP and General CounselMar 04 '25Option Exercise24.0340,000961,200194,204Mar 06 06:48 PM
Kuhlmann Shirley R.EVP and General CounselMar 04 '25Sale28.0840,0001,123,160154,204Mar 06 06:48 PM
Kuhlmann Shirley R.EVP and General CounselMar 06 '25Sale28.5026,067742,946108,137Mar 06 06:48 PM
Kuhlmann Shirley R.EVP and General CounselMar 05 '25Sale28.0320,000560,528134,204Mar 06 06:48 PM
Tupper ColleenOfficerMar 06 '25Proposed Sale30.001,94958,470Mar 06 04:43 PM
Dreyer ScottOfficerMar 06 '25Proposed Sale30.003,29598,854Mar 06 04:31 PM
Kuhlmann Shirley R.OfficerMar 06 '25Proposed Sale28.5026,067742,946Mar 06 10:42 AM
Kuhlmann Shirley R.OfficerMar 05 '25Proposed Sale28.0320,000560,528Mar 05 03:03 PM
Kuhlmann Shirley R.OfficerMar 04 '25Proposed Sale28.0840,0001,123,160Mar 04 04:16 PM
Kuhlmann Shirley R.EVP and General CounselJan 10 '25Option Exercise21.3427,500586,850146,684Jan 14 04:12 PM
Kuhlmann Shirley R.EVP and General CounselJan 10 '25Sale33.0427,500908,628119,184Jan 14 04:12 PM
Kuhlmann Shirley R.OfficerJan 10 '25Proposed Sale33.0427,500908,628Jan 10 04:14 PM
Smith Thomas BEVP and Chief Medical OfficerSep 13 '24Sale36.629,593351,32053,816Sep 17 04:32 PM
Smith Thomas BOfficerSep 13 '24Proposed Sale36.9837313,794Sep 13 10:39 AM
Smith Thomas BOfficerSep 13 '24Proposed Sale36.619,220337,516Sep 13 10:06 AM
Kuhlmann Shirley R.EVP and General CounselSep 05 '24Sale38.3019,248737,198120,161Sep 06 05:52 PM
Kuhlmann Shirley R.EVP and General CounselSep 06 '24Sale37.4697736,594119,184Sep 06 05:52 PM
Kuhlmann Shirley R.OfficerSep 06 '24Proposed Sale37.4697736,594Sep 06 11:53 AM
Kuhlmann Shirley R.OfficerSep 05 '24Proposed Sale38.3019,248737,197Sep 05 04:47 PM
McFarlane Neil F.Former DirectorAug 12 '24Proposed Sale35.2144,3651,562,312Aug 12 02:41 PM
McFarlane Neil F.Former DirectorAug 09 '24Proposed Sale35.205,000176,007Aug 09 04:34 PM